French animal health company Dômes Pharma Group announced on Wednesday the renaming of US-based SentrX Animal Care as Dômes Pharma Inc, strengthening its global brand presence.

This rebranding aligns with the company's aim to expand its global leadership in veterinary ophthalmology and therapeutic specialties.

Additionally, Dômes Pharma has acquired the NeoPolyBac ointment veterinary label from Akorn Pharmaceuticals, a triple antibiotic ophthalmic product with a long history of sales and support in the United States.

Anne Moulin, Dômes Pharma US president, said: "We are delighted to have the US division aligned with our global brand. Veterinarians are engaging with our products, research and technical support on a global level. This change will ensure a consistent experience no matter where they engage with us. In addition, the acquisition of NeoPolyBac and the actions we are taking to re-establish manufacturing is a crucial step toward our goal of addressing unmet needs in veterinary ophthalmology."